FDA Approves Bristol Myers Squibb’s Cobenfy for Schizophrenia
Landmark FDA approval of Cobenfy represents the first new class of drugs indicated to treat schizophrenia in decades.
August 16, 2026
Breaking News
Can an Office harassment lawyer negotiate a settlement? |
Why is Jack Bodenstein gaining attention? |
Which 100 Series Dash Mats offer the best fit and protection? |
Is oven repair Ottawa worth it for older electric and gas ovens? |
How often should organizations conduct a cloud penetration test? |
